Blue Bees Technologye
My visitor profile
BLUE BEES THERAPEUTICS
Description of your activity
- Blue Bees Therapeutics is a biotechnology company dedicated to the development of first-in-class immunotherapies for the treatment of cancers.
More information
-
Our lead product, BB10X, recruits and activates immune cells, therefore aims to cure both hot and also cold tumors as defined immunologically. BB10x can be used as monotherapy or combination therapy on multiple cancer indications.
Based on the Company i.Ther technology, Blue Bees Therapeutics has also established a discovery platform, to develop new immune check-point, alternatively to improve already marketed immune checkpoint inhibitors (biobetters).
Emerging company
Philippe BERTHON
CEO
Nabil GHARIOS
Director, co-founder
Date of your company creation:
- Between 1 & 3 years
Main sector
- Biotechnology - Therapeutics and Diagnostics
Address
- Country : FRANCE
- City : Orsay
- Zip Code : 91400
Participation objectives
Partnering objectives
- Out-licensing / collaboration opportunities, Financing / investment opportunities
Description of my participation objective
- Our objectives are to develop our lead candidate BB10X to Phase II through private equity financing. At the same time, the discovery platform should enable early pharma partnerships.
Communication materials
